Male Hypogonadism Clinical Trial
Official title:
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
The purpose of the study is to determine if oral testosterone undecanoate is effective and safe in the treatment of low testosterone in men.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01446042 -
Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
|
Phase 3 | |
Completed |
NCT02966652 -
Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism
|
Phase 1 | |
Completed |
NCT01228071 -
Time to Eugonadal Range, Time to Steady State and Drying Time
|
Phase 3 | |
Withdrawn |
NCT02715713 -
Autonomic Manifestations of Testosterone Deficiency in Men
|
N/A | |
Completed |
NCT00858650 -
Registry of Hypogonadism in Men
|
N/A | |
Recruiting |
NCT05541172 -
Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
|
||
Not yet recruiting |
NCT04704141 -
Relationship of the Microenvironment and Male Fertility
|
||
Completed |
NCT01403116 -
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
|
Phase 3 | |
Completed |
NCT00924612 -
Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation
|
Phase 2 | |
Completed |
NCT00911586 -
Pharmacokinetic Study to Determine Time to Steady-state
|
Phase 2 | |
Completed |
NCT00475501 -
5-Alpha Reductase and Anabolic Effects of Testosterone
|
Phase 2 | |
Completed |
NCT04708249 -
D-chiroinositol Administration in Hypogonadal Males
|
N/A | |
Completed |
NCT02081300 -
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
|
Phase 3 | |
Active, not recruiting |
NCT03721497 -
Testosterone in Bariatric Patients
|
Phase 4 | |
Completed |
NCT01699178 -
Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men
|
Phase 3 |